New products

Launch of oral health drops, drops with Vitamin D and digestive health tablet with strawberry flavour. Drops that can be stored at room temperature are also launched. 92 clinical studies using BioGaia’s human strains of Lactobacillus reuteri performed in more than 7,700 individuals of all ages. Results published in 55 articles in scientific journals. Net sales of over SEK 300 million. BioGaia’s 50 per cent-owned subsidiary TwoPac builds a new production facility in Eslöv to meet demand for increased volumes. BioGaia goes from listed as Small Cap to Mid Cap at NASDAQ OMX Nordic Exchange Stockholm